News List

Biosense Technologies bags over $1mn in funding from Menterra Venture Advisors

Menterra Venture Advisors has announced a new round of investments in Biosense Technologies, alongside its investment partner Artha Venture Challenge.

By Team ABLE

Menterra Venture Advisors, an impact investment fund that invests in early-stage social startups, has announced a new round of investment in Biosense Technologies alongside its investment partner Artha Venture Challenge, impact investment initiative of the Singh Family Foundation.

Biosense Technologies is a Maharashtra-based startup that provides quality, affordable and connected point-of-care diagnostics solutions for chronic diseases in India. The company was founded by a team of doctors and biomedical engineers with an aim to plug gaps in the provision of preventive care for chronic diseases, especially in non-metro cities and small towns of India.

With the new round, Menterra and Artha have provided more than US$1m of direct equity funding and unlocked soft debt funding of more than US$2m through its network.

Commenting on the investment, Menterra Venture Advisors Head Mukesh Sharma said, “Biosense teams’ bold vision to solve the critical chronic healthcare challenge for our country at scale, never wavered through years of testing and learning. They are one of the few ‘Make in India’ companies creating indigenous glucose strips for diabetes testing.\"

Biosense Technologies operates in the confluence of health, technology and people. It delivers high quality, chronic healthcare solutions, through - ABCD - Affordable Basic Connected Diagnostics. All its products are focused on improving access to healthcare for masses through better use of technology.